Harm Reduction Journal is ready to receive manuscripts on all aspects of minimizing the adverse effects of psychoactive drugs, drug polices, and enforcement.
This journal provides a forum to promote knowledge of harmful microalgae and macroalgae, including cyanobacteria, as well as monitoring, management and control of these organisms. Both original research and review papers will be considered.Papers dealing with the following aspects of harmful microalgae and cyanobacteria in marine and fresh waters will be considered:• The distribution, life histories and taxonomy of harmful microalgae;• The physiology and toxicology of harmful microalgae;• Harmful microalgal bloom ecology;• Trophic, socio-economic, public health and aquacultural impacts of harmful microalgal bloom events;• Occurrence, methods of detection and chemical structure of toxins in harmful microalgae, cyanobacteria, foodwebs and seafood;• Factors controlling toxin production, biosynthesis and chemical ecology.Note: Papers dealing with pharmacology fall outside of the scope of the journal.All papers will be subject to peer review. Authors will receive proofs. The editors, referees, and publisher will make every effort to expedite publication, the co-operation of authors in this task is welcomed.Cover picture by Joe Hlebica, Scripps Institution of Oceanography, Multi-Media Group
As an open access platform of the Harvard Data Science Initiative, the Harvard Data Science Review (HDSR) features foundational thinking, research milestones, educational innovations, and major applications. It aims to publish contents that help to define and shape data science as a scientifically rigorous and globally impactful multidisciplinary field based on the principled and purposed production, processing, parsing and analysis of data. HDSR aims to be a new kind of digital platform that reflects the synergistic nature of data science. By uniting the strengths of a premier research journal, a cutting-edge educational publication, and a popular magazine, HDSR will provide a crossroads at which fundamental data science research and education intersect directly with societally-important applications from industry, governments, NGOs, and others. The platform will foster dialogues among researchers, educators and practitioners about data science research, practice, literacy, and workforce development, thereby enhancing and creating efforts to advance our global community in the rapidly-evolving digital age. In short, HDSR aims to be “everything data science and data science for everyone.”
The Harvard Review of Psychiatry is the authoritative source for scholarly reviews and perspectives on a diverse range of important topics in psychiatry. Founded by the Harvard Medical School Department of Psychiatry, the journal is peer-reviewed and not industry sponsored. It is the property of President and Fellows of Harvard College and is affiliated with all of the Departments of Psychiatry at the Harvard teaching hospitals. Articles encompass all major issues in contemporary psychiatry, including (but not limited to) neuroscience, psychopharmacology, psychotherapy, history of psychiatry, and ethics. In addition to scholarly reviews, perspectives articles, and columns, the journal includes a Clinical Challenge section that presents a case followed by discussion and debate from a panel of experts.